Literature DB >> 30882916

Comparison of electrogram waveforms between a multielectrode mapping catheter and a linear ablation catheter.

Masaharu Masuda1, Mitsutoshi Asai1, Osamu Iida1, Shin Okamoto1, Takayuki Ishihara1, Kiyonori Nanto1, Takashi Kanda1, Takuya Tsujimura1, Yasuhiro Matsuda1, Shota Okuno1, Aki Tsuji1, Toshiaki Mano1.   

Abstract

BACKGROUND: Smaller low-voltage areas (LVAs) obtained by multielectrode catheters were reported than those by linear ablation catheters. However, the underlying electrogram difference has not been elucidated. This study aimed to compare the two mapping catheters' measurements of electrogram waveforms and LVAs.
METHODS: This prospective observational study included 17 consecutive patients undergoing ablation for persistent atrial fibrillation. Following pulmonary vein isolation, voltage mapping during sinus rhythm was performed once using the ablation catheter, and once using the multielectrode catheter. Approximately 20 pairs of mapping points at approximately the same position between the two voltage maps were manually selected evenly throughout the left atrium.
RESULTS: Voltage mapping with the multielectrode catheter demonstrated smaller LVAs, defined as <0.50 mV (5.9 [3.3, 11.0] vs 9.7 [6.6, 16.9] cm2 ) than those mapped with the ablation catheter. The two mapping catheters' voltage amplitudes of all pairs of mapping points correlated well (r = 0.81, P < 0.0001) overall, but they did not correlate within diseased areas (either voltage <0.50 mV). The voltage amplitude difference between the two catheters ([VolMulti  - VolAbl ]/VolAbl × 100) was greater in the diseased areas (37.4% [-9.8%, 147%]) than in the healthy areas (both voltages ≥0.50 mV, 26.2% [-13.0%, 92.8%], P = 0.014). The electrogram waveform of the multiple electrode catheter displayed a higher voltage amplitude, shorter duration, greater number of peaks, and lower dull peak ratio (number of dull peaks/total peaks) than that of the ablation catheter.
CONCLUSION: The multielectrode catheter produced smaller LVA measurements with sharper and higher voltage electrograms compared to the ablation catheter, specifically in diseased areas.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  electrogram; low-voltage area; mapping catheters; voltage map

Mesh:

Year:  2019        PMID: 30882916     DOI: 10.1111/pace.13644

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  4 in total

1.  High Brain Natriuretic Peptide Level Predicts The Prevalence Of Low-Voltage Areas And Poor Rhythm Outcome In Patients Undergoing Atrial Fibrillation Ablation.

Authors:  Yasuhiro Matsuda; Masaharu Masuda; Mitsutoshi Asai; Osamu Iida; Shin Okamoto; Takayuki Ishihara; Kiyonori Nanto; Takashi Kanda; Takuya Tsujimura; Shota Okuno; Yosuke Hata; Hiroyuki Uematsu; Toshiaki Mano
Journal:  J Atr Fibrillation       Date:  2020-10-31

2.  Low-Voltage Areas as Alternative Targets for the Ablation of Unmappable Atrial Tachycardia in Patients Undergoing Atrial Fibrillation Ablation.

Authors:  Masaharu Masuda; Mitsutoshi Asai; Osamu Iida; Shin Okamoto; Takayuki Ishihara; Kiyonori Nanto; Takashi Kanda; Takuya Tsujimura; Yasuhiro Matsuda; Shota Okuno; Toshiaki Mano
Journal:  J Atr Fibrillation       Date:  2020-08-31

3.  Extensive Left Atrial Low-Voltage Area During Initial Ablation is Associated with A Poor Clinical Outcome Even Following Multiple Procedures.

Authors:  Takashi Kanda; Masaharu Masuda; Mitsutoshi Asai; Osamu Iida; Shin Okamoto; Takayuki Ishihara; Kiyonori Nanto; Takuya Tsujimura; Yasuhiro Matsuda; Yosuke Hata; Hiroyuki Uematsu; Toshiaki Mano
Journal:  J Atr Fibrillation       Date:  2021-08-31

4.  Pre-procedural predictors of left atrial low-voltage zones in patients undergoing catheter ablation of atrial fibrillation.

Authors:  Takenori Ikoma; Yoshihisa Naruse; Yutaro Kaneko; Tomoaki Sakakibara; Taro Narumi; Makoto Sano; Satoshi Mogi; Kenichiro Suwa; Hayato Ohtani; Masao Saotome; Tsuyoshi Urushida; Yuichiro Maekawa
Journal:  PLoS One       Date:  2022-04-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.